Pinnacle Financial Group, Inc.’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
Pinnacle Financial Group, Inc.'s PBE Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. reported 2,462 shares of Invesco Biotechnology & Genome ETF (PBE) worth $240K in Q3 2026. The position accounts for 0.02% of the portfolio, ranked #426.
123 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Pinnacle Financial Group, Inc. held 2,462 shares of Invesco Biotechnology & Genome ETF worth $240K as of Q3 2026.
- Invesco Biotechnology & Genome ETF made up 0.02% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #426 holding.
- 123 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.